omega-(4-iodophenyl)pentadecanoic acid has been researched along with tripalmitin in 1 studies
| Studies (omega-(4-iodophenyl)pentadecanoic acid) | Trials (omega-(4-iodophenyl)pentadecanoic acid) | Recent Studies (post-2010) (omega-(4-iodophenyl)pentadecanoic acid) | Studies (tripalmitin) | Trials (tripalmitin) | Recent Studies (post-2010) (tripalmitin) |
|---|---|---|---|---|---|
| 119 | 6 | 4 | 189 | 4 | 72 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Counsell, RE; Gross, MD; Longino, MA; Schwendner, SW; Weichert, JP | 1 |
1 other study(ies) available for omega-(4-iodophenyl)pentadecanoic acid and tripalmitin
| Article | Year |
|---|---|
Potential organ or tumor imaging agents. 32. A triglyceride ester of p-iodophenyl pentadecanoic acid as a potential hepatic imaging agent.
Topics: Animals; Diabetes Mellitus, Experimental; Dogs; Evaluation Studies as Topic; Female; Gamma Cameras; Humans; Iodine Radioisotopes; Iodobenzenes; Lipase; Lipoproteins; Liver; Models, Biological; Neoplasms; Phosphatidylglycerols; Radionuclide Imaging; Rats; Rats, Inbred Strains; Tissue Distribution; Triglycerides; Triolein | 1992 |